Jazz Pharmaceuticals (JAZZ) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
Jazz Pharmaceuticals · Health Care · ref. ETF XLV · 128 calls · price $251.1
What the company does: Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.
📈 Jazz Pharmaceuticals (JAZZ) stock price
$251.1+99.1% over range
Aug 28, 25low $125.22 · high $261.62Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
94% recommend buying · 16 analysts
📊 JPI status : Jazz Pharmaceuticals is no longer in our current JPI rankings, but appeared in the past (2022) — its upside may be behind it. See the stocks picked in 2022 →
🎯 JAZZ price target & analyst consensus — price $251
The price target · all analysts combined (16 targets)
Highest target · 1 firm of 16$310+23.5%
Median target · of 16 targets$281.5+12.1%
Lowest target · 1 firm of 16$225-10.4%
Current price$251.1
Where these 16 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
1488%
$258 ↔ $310
Below
213%
$225 ↔ $229
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: B of A Securities — 74% of its targets hit on this sector (105 calls tested). It aims for $307 (+22 %), call made on June 11, 2026, maturing on June 11, 2027 (78 d ago).
The 7 reliable analysts
$290+16 %
The 9 other firms
$276+9.9 %
How to read it: the 7 reliable firms are not filtered by optimism — 7 aim above the price, 0 below, hence their $290 median. “The 9 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 16 ratings (last 6 months)
Strong Buy00%
Buy1594%
Hold16%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 JAZZ price target all
All 17 calls, one by one, with our verdict on each firm.
→ See all 17 targets, analyst by analyst💡 The best analysts on JAZZ most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in JAZZ? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Jazz Pharmaceuticals? The JPI assistant answers using our backtest data.
📈 Jazz Pharmaceuticals fundamentals: valuation, margins & growth › open the full page
P/E 17.2Net margin 20.4 %Revenue growth +15.5 %Cheap for the growth
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. -6 %
2023
Rev +5%
2024
Rev +6%Profit +35%
2025
Rev +5%Profit −164%
🔎 Detailed analyses
✅ Historical analyst reliability on JAZZ
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Oppenheimer ↗ | 100% | +33.1% | 3 |
| JP Morgan ↗ | 100% | +22.3% | 6 |
| Truist Securities ↗ | 100% | +15.7% | 3 |
| Wells Fargo ↗ | 86% | +18.5% | 7 |
| Citigroup ↗ | 83% | +53.5% | 6 |
| Jefferies ↗ | 80% | +29.9% | 5 |
| Morgan Stanley ↗ | 75% | +88.5% | 4 |
| Baird ↗ | 75% | +45.7% | 4 |
| Cantor Fitzgerald ↗ | 70% | +24.6% | 10 |
| Piper Sandler ↗ | 69% | +37.2% | 13 |
See the other 15 firms
| B. Riley Securities ↗ | 0% | -16.3% | 3 |
| Leerink Swann | 20% | -5.3% | 5 |
| BMO Capital ↗ | 30% | -0.2% | 10 |
| SVB Leerink | 38% | +7.2% | 8 |
| HC Wainwright & Co. ↗ | 44% | +3.1% | 16 |
| Mizuho ↗ | 50% | -0.8% | 2 |
| Goldman Sachs ↗ | 50% | +6.9% | 6 |
| Barclays ↗ | 56% | +14.1% | 9 |
| SunTrust Robinson Humphrey | 60% | +16.4% | 5 |
| UBS ↗ | 60% | +31.4% | 10 |
| B of A Securities ↗ | 60% | +58.3% | 5 |
| RBC Capital ↗ | 62% | +14.7% | 16 |
| Stifel ↗ | 62% | +26.6% | 8 |
| Needham ↗ | 64% | +23.1% | 28 |
| Deutsche Bank ↗ | 67% | +3.4% | 6 |
📊 What $1,000 invested in Jazz Pharmaceuticals would be worth › open the full page
In short — $1,000 invested in Jazz Pharmaceuticals 10 years ago would be worth $1,714 today, i.e. +6%/yr on average. Best year: 2025 (+38%), worst: 2021 (-23%). Price performance, excluding dividends.
If I'd invested $1,000 in Jazz Pharmaceuticals
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $1,957 | +96% |
| 3 years ago | $1,513 | +51% |
| 5 years ago | $1,460 | +46% |
Return by year (Jazz Pharmaceuticals)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +42% | $1,417 (+42%) |
| 2025 | +38% | $1,957 (+96%) |
| 2024 | +0% | $1,959 (+96%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Jazz Pharmaceuticals
Loading news…
📋 All analyst calls on JAZZ
Filtered on — · ✕ show all
Morgan Stanley ↗
Aug 11, 26
▲ Overweight · 🎯$283
Price at call : $248.95 — upside +14%
Today : $251.1 — upside +13%
🎯 on JAZZ : no call matured yet · 📊 on Health : 41.3% · -1.5% (196 calls)
in progress (365j)
matures : Aug 11, 27
matures : Aug 11, 27
▲ Overweight · 🎯$276
Price at call : $261.57 — upside +6%
Today : $251.1 — upside +10%
🎯 on JAZZ : no call matured yet · 📊 on Health : 49.3% · +6.2% (142 calls)
in progress (365j)
matures : Aug 4, 27
matures : Aug 4, 27
Truist Securities ↗
Aug 4, 26
▲ Buy · 🎯$264
Price at call : $261.57 — upside +1%
Today : $251.1 — upside +5%
🎯 on JAZZ : no call matured yet · 📊 on Health : 58.7% · +5.8% (109 calls)
in progress (365j)
matures : Aug 4, 27
matures : Aug 4, 27
▲ Buy · 🎯$300
Price at call : $261.57 — upside +15%
Today : $251.1 — upside +19%
🎯 on JAZZ : no call matured yet · 📊 on Health : 53.8% · +17.8% (26 calls)
in progress (365j)
matures : Aug 4, 27
matures : Aug 4, 27
Wells Fargo ↗
Aug 4, 26
▲ Overweight · 🎯$300
Price at call : $261.62 — upside +15%
Today : $251.1 — upside +19%
🎯 on JAZZ : no call matured yet · 📊 on Health : 47% · +4.6% (149 calls)
in progress (365j)
matures : Aug 4, 27
matures : Aug 4, 27
Morgan Stanley ↗
Aug 4, 26
▲ Overweight · 🎯$280
Price at call : $261.62 — upside +7%
Today : $251.1 — upside +12%
🎯 on JAZZ : no call matured yet · 📊 on Health : 41.3% · -1.5% (196 calls)
in progress (365j)
matures : Aug 4, 27
matures : Aug 4, 27
Piper Sandler ↗
Aug 4, 26
▲ Overweight · 🎯$310
Price at call : $261.62 — upside +18%
Today : $251.1 — upside +23%
🎯 on JAZZ : 67% (12 calls matureds) · 📊 on Health : 42.5% · +4.1% (120 calls)
in progress (365j)
matures : Aug 4, 27
matures : Aug 4, 27
▲ Buy · 🎯$292
Price at call : $261.62 — upside +12%
Today : $251.1 — upside +16%
🎯 on JAZZ : 100% (12 calls matureds) · 📊 on Health : 46% · +1.9% (137 calls)
in progress (365j)
matures : Aug 4, 27
matures : Aug 4, 27
See the other 120 calls, newest to oldest
▲ Overweight · 🎯$270
Price at call : $261.62 — upside +3%
Today : $251.1 — upside +8%
🎯 on JAZZ : no call matured yet · 📊 on Health : 47.9% · +1.6% (194 calls)
in progress (365j)
matures : Aug 4, 27
matures : Aug 4, 27
▲ Outperform · 🎯$280
Price at call : $261.62 — upside +7%
Today : $251.1 — upside +12%
🎯 on JAZZ : no call matured yet · 📊 on Health : 48.7% · +1.8% (76 calls)
in progress (365j)
matures : Aug 4, 27
matures : Aug 4, 27
▲ Buy · 🎯$282
Price at call : $243.47 — upside +16%
Today : $251.1 — upside +12%
🎯 on JAZZ : 100% (12 calls matureds) · 📊 on Health : 46% · +1.9% (137 calls)
in progress (365j)
matures : Jul 20, 27
matures : Jul 20, 27
Canaccord Genuity ↗
Jul 17, 26
▲ Buy · 🎯$290
Price at call : $247.53 — upside +17%
Today : $251.1 — upside +15%
🎯 on JAZZ : no call matured yet · 📊 on Health : 53.3% · +6.6% (92 calls)
in progress (365j)
matures : Jul 17, 27
matures : Jul 17, 27
Wells Fargo ↗
Jul 14, 26
▲ Overweight · 🎯$285
Price at call : $238.05 — upside +20%
Today : $251.1 — upside +14%
🎯 on JAZZ : no call matured yet · 📊 on Health : 47% · +4.6% (149 calls)
in progress (365j)
matures : Jul 14, 27
matures : Jul 14, 27
▲ Overweight · 🎯$260
Price at call : $238.05 — upside +9%
Today : $251.1 — upside +4%
🎯 on JAZZ : no call matured yet · 📊 on Health : 47.9% · +1.6% (194 calls)
in progress (365j)
matures : Jul 14, 27
matures : Jul 14, 27
Deutsche Bank ↗
Jul 9, 26
▲ Buy · 🎯$270
Price at call : $243.82 — upside +11%
Today : $251.1 — upside +8%
🎯 on JAZZ : no call matured yet · 📊 on Health : 53.8% · +9.7% (80 calls)
in progress (365j)
matures : Jul 9, 27
matures : Jul 9, 27
Truist Securities ↗
Jul 7, 26
▲ Buy · 🎯$254
Price at call : $247.72 — upside +3%
Today : $251.1 — upside +1%
🎯 on JAZZ : no call matured yet · 📊 on Health : 58.7% · +5.8% (109 calls)
in progress (365j)
matures : Jul 7, 27
matures : Jul 7, 27
B of A Securities ↗
Jun 10, 26
▲ Buy · 🎯$307
Price at call : $229.63 — upside +34%
Today : $251.1 — upside +22%
🎯 on JAZZ : no call matured yet · 📊 on Health : 64.8% · +20.2% (105 calls)
in progress (365j)
matures : Jun 10, 27
matures : Jun 10, 27
▲ Overweight · 🎯$253
Price at call : $235.38 — upside +7%
Today : $251.1 — upside +1%
🎯 on JAZZ : no call matured yet · 📊 on Health : 47.9% · +1.6% (194 calls)
in progress (365j)
matures : May 27, 27
matures : May 27, 27
■ Market Perform neutral · not a buy · 🎯$229
Price at call : $237.41 — gap to target -4%
Today : $251.1 — gap to target -9%
🎯 on JAZZ : no call matured yet · 📊 on Health : 50% · -5.0% (6 calls)
in progress (365j)
matures : May 22, 27
matures : May 22, 27
Piper Sandler ↗
May 22, 26
▲ Overweight · 🎯$301
Price at call : $239.83 — upside +26%
Today : $251.1 — upside +20%
🎯 on JAZZ : 67% (12 calls matureds) · 📊 on Health : 42.5% · +4.1% (120 calls)
in progress (365j)
matures : May 22, 27
matures : May 22, 27
▲ Buy · 🎯$307
Price at call : $239.01 — upside +28%
Today : $251.1 — upside +22%
🎯 on JAZZ : 60% (10 calls matureds) · 📊 on Health : 49.6% · +18.1% (119 calls)
in progress (365j)
matures : May 19, 27
matures : May 19, 27
▲ Buy · 🎯$275
Price at call : $226.96 — upside +21%
Today : $251.1 — upside +10%
🎯 on JAZZ : no call matured yet · 📊 on Health : 53.8% · +17.8% (26 calls)
in progress (365j)
matures : May 6, 27
matures : May 6, 27
RBC Capital ↗
May 6, 26
▲ Outperform · 🎯$258
Price at call : $226.96 — upside +14%
Today : $251.1 — upside +3%
🎯 on JAZZ : 75% (12 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
in progress (365j)
matures : May 6, 27
matures : May 6, 27
▲ Overweight · 🎯$234
Price at call : $226.96 — upside +3%
Today : $251.1 — upside -7%
🎯 on JAZZ : no call matured yet · 📊 on Health : 47.9% · +1.6% (194 calls)
in progress (365j)
matures : May 6, 27
matures : May 6, 27
Wells Fargo ↗
May 6, 26
▲ Overweight · 🎯$265
Price at call : $226.96 — upside +17%
Today : $251.1 — upside +6%
🎯 on JAZZ : no call matured yet · 📊 on Health : 47% · +4.6% (149 calls)
in progress (365j)
matures : May 6, 27
matures : May 6, 27
▲ Buy · 🎯$255
Price at call : $196.52 — upside +30%
Today : $251.1 — upside +2%
🎯 on JAZZ : 100% (12 calls matureds) · 📊 on Health : 46% · +1.9% (137 calls)
in progress (365j)
matures : Apr 24, 27
matures : Apr 24, 27
Leerink Partners ↗
Apr 22, 26
▲ Outperform · 🎯$225
Price at call : $199.96 — upside +13%
Today : $251.1 — upside -10%
🎯 on JAZZ : no call matured yet · 📊 on Health : 54.5% · +10.0% (11 calls)
in progress (365j)
matures : Apr 22, 27
matures : Apr 22, 27
▲ Overweight · 🎯$225
Price at call : $199.03 — upside +13%
Today : $251.1 — upside -10%
🎯 on JAZZ : no call matured yet · 📊 on Health : 47.9% · +1.6% (194 calls)
in progress (365j)
matures : Apr 20, 27
matures : Apr 20, 27
Piper Sandler ↗
Mar 19, 26
▲ Overweight · 🎯$232
Price at call : $180.62 — upside +28%
Today : $251.1 — upside -8%
🎯 on JAZZ : 67% (12 calls matureds) · 📊 on Health : 42.5% · +4.1% (120 calls)
in progress (365j)
matures : Mar 19, 27
matures : Mar 19, 27
▲ Overweight · 🎯$224
Price at call : $190.02 — upside +18%
Today : $251.1 — upside -11%
🎯 on JAZZ : no call matured yet · 📊 on Health : 47.9% · +1.6% (194 calls)
in progress (365j)
matures : Feb 27, 27
matures : Feb 27, 27
RBC Capital ↗
Feb 25, 26
▲ Outperform · 🎯$195
Price at call : $188.97 — upside +3%
Today : $251.1 — upside -22%
🎯 on JAZZ : 75% (12 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
Morgan Stanley ↗
Feb 25, 26
▲ Overweight · 🎯$226
Price at call : $188.97 — upside +20%
Today : $251.1 — upside -10%
🎯 on JAZZ : no call matured yet · 📊 on Health : 41.3% · -1.5% (196 calls)
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
Wells Fargo ↗
Feb 25, 26
▲ Overweight · 🎯$250
Price at call : $188.97 — upside +32%
Today : $251.1 — upside -0%
🎯 on JAZZ : no call matured yet · 📊 on Health : 47% · +4.6% (149 calls)
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
B of A Securities ↗
Feb 25, 26
▲ Buy · 🎯$275
Price at call : $196.83 — upside +40%
Today : $251.1 — upside +10%
🎯 on JAZZ : no call matured yet · 📊 on Health : 64.8% · +20.2% (105 calls)
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
Truist Securities ↗
Jan 12, 26
▲ Buy · 🎯$230
Price at call : $162.43 — upside +42%
Today : $251.1 — upside -8%
🎯 on JAZZ : no call matured yet · 📊 on Health : 58.7% · +5.8% (109 calls)
in progress (365j)
matures : Jan 12, 27
matures : Jan 12, 27
▲ Buy · 🎯$235
Price at call : $163.68 — upside +44%
Today : $251.1 — upside -6%
🎯 on JAZZ : 100% (12 calls matureds) · 📊 on Health : 46% · +1.9% (137 calls)
in progress (365j)
matures : Jan 12, 27
matures : Jan 12, 27
Piper Sandler ↗
Dec 10, 25
▲ Overweight · 🎯$219
Price at call : $164.89 — upside +33%
Today : $251.1 — upside -13%
🎯 on JAZZ : 67% (12 calls matureds) · 📊 on Health : 42.5% · +4.1% (120 calls)
in progress (365j)
matures : Dec 10, 26
matures : Dec 10, 26
■ Neutral neutral · not a buy · 🎯$188
Price at call : $180.9 — gap to target +4%
Today : $251.1 — gap to target -25%
🎯 on JAZZ : 60% (10 calls matureds) · 📊 on Health : 49.6% · +18.1% (119 calls)
in progress (365j)
matures : Nov 24, 26
matures : Nov 24, 26
Wells Fargo ↗
Nov 18, 25
▲ Overweight · 🎯$235
Price at call : $176.08 — upside +33%
Today : $251.1 — upside -6%
🎯 on JAZZ : no call matured yet · 📊 on Health : 47% · +4.6% (149 calls)
in progress (365j)
matures : Nov 18, 26
matures : Nov 18, 26
▲ Outperform · 🎯$209
Price at call : $176.08 — upside +19%
Today : $251.1 — upside -17%
🎯 on JAZZ : no call matured yet · 📊 on Health : 48.7% · +1.8% (76 calls)
in progress (365j)
matures : Nov 18, 26
matures : Nov 18, 26
B of A Securities ↗
Nov 18, 25
▲ Buy · 🎯$247
Price at call : $180.52 — upside +37%
Today : $251.1 — upside -2%
🎯 on JAZZ : no call matured yet · 📊 on Health : 64.8% · +20.2% (105 calls)
in progress (365j)
matures : Nov 18, 26
matures : Nov 18, 26
RBC Capital ↗
Nov 17, 25
▲ Outperform · 🎯$194
Price at call : $180.52 — upside +7%
Today : $251.1 — upside -23%
🎯 on JAZZ : 75% (12 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
in progress (365j)
matures : Nov 17, 26
matures : Nov 17, 26
Morgan Stanley ↗
Nov 17, 25
▲ Overweight · 🎯$205
Price at call : $180.52 — upside +14%
Today : $251.1 — upside -18%
🎯 on JAZZ : no call matured yet · 📊 on Health : 41.3% · -1.5% (196 calls)
in progress (365j)
matures : Nov 17, 26
matures : Nov 17, 26
RBC Capital ↗
Nov 6, 25
▲ Outperform · 🎯$155
Price at call : $131.16 — upside +18%
Today : $251.1 — upside -38%
🎯 on JAZZ : 75% (12 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
in progress (365j)
matures : Nov 6, 26
matures : Nov 6, 26
▲ Overweight · 🎯$199
Price at call : $138.13 — upside +44%
Today : $251.1 — upside -21%
🎯 on JAZZ : no call matured yet · 📊 on Health : 49.3% · +6.2% (142 calls)
in progress (365j)
matures : Oct 27, 26
matures : Oct 27, 26
Morgan Stanley ↗
Oct 20, 25
▲ Overweight · 🎯$180
Price at call : $137.5 — upside +31%
Today : $251.1 — upside -28%
🎯 on JAZZ : no call matured yet · 📊 on Health : 41.3% · -1.5% (196 calls)
in progress (365j)
matures : Oct 20, 26
matures : Oct 20, 26
Morgan Stanley ↗
Sep 24, 25
▲ Overweight · 🎯$167
Price at call : $129.59 — upside +29%
Today : $251.1 — upside -33%
🎯 on JAZZ : no call matured yet · 📊 on Health : 41.3% · -1.5% (196 calls)
in progress (365j)
matures : Sep 24, 26
matures : Sep 24, 26
Goldman Sachs ↗
Aug 29, 25
▲ Buy · 🎯$185
Price at call : $129.66 — upside +43%
Today : $251.1 — upside -26%
🎯 on JAZZ : no call matured yet · 📊 on Health : 57.9% · +13.8% (107 calls)
in progress (365j)
matures : Aug 29, 26
matures : Aug 29, 26
Morgan Stanley ↗
Aug 28, 25
▲ Overweight · 🎯$163
Price at call : $127.75 — upside +28%
Today : $251.1 — upside -35%
🎯 on JAZZ : no call matured yet · 📊 on Health : 41.3% · -1.5% (196 calls)
in progress (365j)
matures : Aug 28, 26
matures : Aug 28, 26
RBC Capital ↗
Aug 28, 25
▲ Outperform · 🎯$151
Price at call : $127.75 — upside +18%
Today : $251.1 — upside -40%
🎯 on JAZZ : 75% (12 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
in progress (365j)
matures : Aug 28, 26
matures : Aug 28, 26
▲ Buy · 🎯$202
Price at call : $119.07 — upside +70%
Today : $251.1 — upside -20%
Expected +70% · Actual +109% · Reason (≥ +15%) : ✓ Yes
🎯 on JAZZ : 100% (12 calls matureds) · 📊 on Health : 46% · +1.9% (137 calls)
+108.9%
stock +109% · XLV +25%
matured Aug 20, 26
▲ Buy · 🎯$202
Price at call : $110.5 — upside +83%
Today : $251.1 — upside -20%
Expected +83% · Actual +114% · Reason (≥ +15%) : ✓ Yes
🎯 on JAZZ : 100% (12 calls matureds) · 📊 on Health : 46% · +1.9% (137 calls)
+113.7%
stock +114% · XLV +14%
matured Jun 11, 26
▲ Buy · 🎯$202
Price at call : $110.32 — upside +83%
Today : $251.1 — upside -20%
Expected +83% · Actual +109% · Reason (≥ +15%) : ✓ Yes
🎯 on JAZZ : 100% (12 calls matureds) · 📊 on Health : 46% · +1.9% (137 calls)
+109.3%
stock +109% · XLV +11%
matured Jun 3, 26
RBC Capital ↗
May 7, 25
▲ Outperform · 🎯$172
Price at call : $98.41 — upside +75%
Today : $251.1 — upside -32%
Expected +75% · Actual +129% · Reason (≥ +15%) : ✓ Yes
🎯 on JAZZ : 75% (12 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
+129.4%
stock +129% · XLV +7%
matured May 7, 26
Piper Sandler ↗
May 7, 25
▲ Overweight · 🎯$147
Price at call : $98.41 — upside +49%
Today : $251.1 — upside -41%
Expected +49% · Actual +129% · Reason (≥ +15%) : ✓ Yes
🎯 on JAZZ : 67% (12 calls matureds) · 📊 on Health : 42.5% · +4.1% (120 calls)
+129.4%
stock +129% · XLV +7%
matured May 7, 26
▲ Buy · 🎯$200
Price at call : $101.44 — upside +97%
Today : $251.1 — upside -20%
Expected +97% · Actual +124% · Reason (≥ +15%) : ✓ Yes
🎯 on JAZZ : 100% (12 calls matureds) · 📊 on Health : 46% · +1.9% (137 calls)
+123.7%
stock +124% · XLV +7%
matured May 7, 26
▲ Buy · 🎯$210
Price at call : $102.05 — upside +106%
Today : $251.1 — upside -16%
Expected +106% · Actual +90% · Reason (≥ +15%) : ✓ Yes
🎯 on JAZZ : 100% (12 calls matureds) · 📊 on Health : 46% · +1.9% (137 calls)
+90.3%
stock +90% · XLV +9%
matured Apr 10, 26
HC Wainwright & Co. ↗
Mar 10, 25
▲ Buy · 🎯$217
Price at call : $137.45 — upside +58%
Today : $251.1 — upside -14%
Expected +58% · Actual +35% · Reason (≥ +15%) : ✓ Yes
🎯 on JAZZ : 50% (12 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
+35.3%
stock +35% · XLV +4%
matured Mar 10, 26
▲ Buy · 🎯$179
Price at call : $138.81 — upside +29%
Today : $251.1 — upside -29%
Expected +29% · Actual +34% · Reason (≥ +15%) : ✓ Yes
🎯 on JAZZ : 60% (10 calls matureds) · 📊 on Health : 49.6% · +18.1% (119 calls)
+33.6%
stock +34% · XLV +3%
matured Mar 7, 26
▲ Buy · 🎯$210
Price at call : $136.45 — upside +54%
Today : $251.1 — upside -16%
Expected +54% · Actual +33% · Reason (≥ +15%) : ✓ Yes
🎯 on JAZZ : 100% (12 calls matureds) · 📊 on Health : 46% · +1.9% (137 calls)
+33.4%
stock +33% · XLV +2%
matured Mar 5, 26
Piper Sandler ↗
Feb 26, 25
▲ Overweight · 🎯$176
Price at call : $143.27 — upside +23%
Today : $251.1 — upside -30%
Expected +23% · Actual +33% · Reason (≥ +15%) : ✓ Yes
🎯 on JAZZ : 67% (12 calls matureds) · 📊 on Health : 42.5% · +4.1% (120 calls)
+32.6%
stock +33% · XLV +9%
matured Feb 26, 26
RBC Capital ↗
Feb 26, 25
▲ Outperform · 🎯$178
Price at call : $143.27 — upside +24%
Today : $251.1 — upside -29%
Expected +24% · Actual +33% · Reason (≥ +15%) : ✓ Yes
🎯 on JAZZ : 75% (12 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
+32.6%
stock +33% · XLV +9%
matured Feb 26, 26
▲ Buy · 🎯$210
Price at call : $144.17 — upside +46%
Today : $251.1 — upside -16%
Expected +46% · Actual +31% · Reason (≥ +15%) : ✓ Yes
🎯 on JAZZ : 100% (12 calls matureds) · 📊 on Health : 46% · +1.9% (137 calls)
+31.1%
stock +31% · XLV +6%
matured Feb 26, 26
Piper Sandler ↗
Dec 12, 24
▲ Overweight · 🎯$163
Price at call : $123.04 — upside +32%
Today : $251.1 — upside -35%
Expected +32% · Actual +38% · Reason (≥ +15%) : ✓ Yes
🎯 on JAZZ : 67% (12 calls matureds) · 📊 on Health : 42.5% · +4.1% (120 calls)
+37.8%
stock +38% · XLV +11%
matured Dec 12, 25
RBC Capital ↗
Dec 12, 24
▲ Outperform · 🎯$179
Price at call : $123.04 — upside +45%
Today : $251.1 — upside -29%
Expected +45% · Actual +38% · Reason (≥ +15%) : ✓ Yes
🎯 on JAZZ : 75% (12 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
+37.8%
stock +38% · XLV +11%
matured Dec 12, 25
▲ Buy · 🎯$207
Price at call : $123.6 — upside +67%
Today : $251.1 — upside -18%
Expected +67% · Actual +36% · Reason (≥ +15%) : ✓ Yes
🎯 on JAZZ : 100% (12 calls matureds) · 📊 on Health : 46% · +1.9% (137 calls)
+35.5%
stock +36% · XLV +9%
matured Dec 12, 25
RBC Capital ↗
Dec 10, 24
▲ Outperform · 🎯$179
Price at call : $120.72 — upside +48%
Today : $251.1 — upside -29%
Expected +48% · Actual +37% · Reason (≥ +15%) : ✓ Yes
🎯 on JAZZ : 75% (12 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
+36.6%
stock +37% · XLV +8%
matured Dec 10, 25
HC Wainwright & Co. ↗
Nov 22, 24
▲ Buy · 🎯$200
Price at call : $126.67 — upside +58%
Today : $251.1 — upside -20%
Expected +58% · Actual +43% · Reason (≥ +15%) : ✓ Yes
🎯 on JAZZ : 50% (12 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
+42.8%
stock +43% · XLV +8%
matured Nov 22, 25
▲ Buy · 🎯$207
Price at call : $126.67 — upside +63%
Today : $251.1 — upside -18%
Expected +63% · Actual +43% · Reason (≥ +15%) : ✓ Yes
🎯 on JAZZ : 100% (12 calls matureds) · 📊 on Health : 46% · +1.9% (137 calls)
+42.8%
stock +43% · XLV +8%
matured Nov 21, 25
Piper Sandler ↗
Nov 21, 24
▲ Overweight · 🎯$163
Price at call : $125.1 — upside +30%
Today : $251.1 — upside -35%
Expected +30% · Actual +41% · Reason (≥ +15%) : ✓ Yes
🎯 on JAZZ : 67% (12 calls matureds) · 📊 on Health : 42.5% · +4.1% (120 calls)
+41.4%
stock +41% · XLV +7%
matured Nov 21, 25
▲ Buy · 🎯$207
Price at call : $119.08 — upside +74%
Today : $251.1 — upside -18%
Expected +74% · Actual +10% · Reason (≥ +15%) : ✗ No
🎯 on JAZZ : 100% (12 calls matureds) · 📊 on Health : 46% · +1.9% (137 calls)
+10.1%
stock +10% · XLV -2%
matured Nov 7, 25
RBC Capital ↗
Oct 23, 24
▲ Outperform · 🎯$179
Price at call : $108.05 — upside +66%
Today : $251.1 — upside -29%
Expected +66% · Actual +28% · Reason (≥ +15%) : ✓ Yes
🎯 on JAZZ : 75% (12 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
+28.2%
stock +28% · XLV -2%
matured Oct 23, 25
RBC Capital ↗
Oct 4, 24
▲ Outperform · 🎯$175
Price at call : $108.52 — upside +61%
Today : $251.1 — upside -30%
Expected +61% · Actual +27% · Reason (≥ +15%) : ✓ Yes
🎯 on JAZZ : 75% (12 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
+26.8%
stock +27% · XLV -5%
matured Oct 4, 25
▲ Buy · 🎯$205
Price at call : $107.1 — upside +91%
Today : $251.1 — upside -18%
Expected +91% · Actual +18% · Reason (≥ +15%) : ✓ Yes
🎯 on JAZZ : 100% (12 calls matureds) · 📊 on Health : 46% · +1.9% (137 calls)
+18.5%
stock +18% · XLV -12%
matured Sep 10, 25
Cantor Fitzgerald ↗
Sep 9, 24
▲ Overweight · 🎯$140
Price at call : $107.1 — upside +31%
Today : $251.1 — upside -44%
Expected +31% · Actual +18% · Reason (≥ +15%) : ✓ Yes
🎯 on JAZZ : 70% (10 calls matureds) · 📊 on Health : 55.7% · +17.4% (115 calls)
+18.5%
stock +18% · XLV -12%
matured Sep 9, 25
Cantor Fitzgerald ↗
Aug 1, 24
▲ Overweight · 🎯$140
Price at call : $113.26 — upside +24%
Today : $251.1 — upside -44%
Expected +24% · Actual +3% · Reason (≥ +15%) : ✗ No
🎯 on JAZZ : 70% (10 calls matureds) · 📊 on Health : 55.7% · +17.4% (115 calls)
+2.5%
stock +3% · XLV -12%
matured Aug 1, 25
Piper Sandler ↗
Aug 1, 24
▲ Overweight · 🎯$166
Price at call : $113.26 — upside +47%
Today : $251.1 — upside -34%
Expected +47% · Actual +3% · Reason (≥ +15%) : ✗ No
🎯 on JAZZ : 67% (12 calls matureds) · 📊 on Health : 42.5% · +4.1% (120 calls)
+2.5%
stock +3% · XLV -12%
matured Aug 1, 25
RBC Capital ↗
Aug 1, 24
▲ Outperform · 🎯$174
Price at call : $113.26 — upside +54%
Today : $251.1 — upside -31%
Expected +54% · Actual +3% · Reason (≥ +15%) : ✗ No
🎯 on JAZZ : 75% (12 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
+2.5%
stock +3% · XLV -12%
matured Aug 1, 25
▲ Buy · 🎯$205
Price at call : $114.38 — upside +79%
Today : $251.1 — upside -18%
Expected +79% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on JAZZ : 100% (12 calls matureds) · 📊 on Health : 46% · +1.9% (137 calls)
+1.0%
stock +1% · XLV -13%
matured Aug 1, 25
HC Wainwright & Co. ↗
Aug 1, 24
▲ Buy · 🎯$200
Price at call : $114.38 — upside +75%
Today : $251.1 — upside -20%
Expected +75% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on JAZZ : 50% (12 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
+1.0%
stock +1% · XLV -13%
matured Aug 1, 25
HC Wainwright & Co. ↗
May 3, 24
▲ Buy · 🎯$200
Price at call : $109.85 — upside +82%
Today : $251.1 — upside -20%
Expected +82% · Actual +8% · Reason (≥ +15%) : ✗ No
🎯 on JAZZ : 50% (12 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
+7.6%
stock +8% · XLV -2%
matured May 3, 25
Cantor Fitzgerald ↗
Apr 10, 24
▲ Overweight · 🎯$180
Price at call : $113.49 — upside +59%
Today : $251.1 — upside -28%
Expected +59% · Actual -11% · Reason (≥ +15%) : ✗ No
🎯 on JAZZ : 70% (10 calls matureds) · 📊 on Health : 55.7% · +17.4% (115 calls)
-11.5%
stock -11% · XLV -3%
matured Apr 10, 25
Cantor Fitzgerald ↗
Mar 22, 24
▲ Overweight · 🎯$180
Price at call : $120.79 — upside +49%
Today : $251.1 — upside -28%
Expected +49% · Actual +18% · Reason (≥ +15%) : ✓ Yes
🎯 on JAZZ : 70% (10 calls matureds) · 📊 on Health : 55.7% · +17.4% (115 calls)
+17.6%
stock +18% · XLV +1%
matured Mar 22, 25
Piper Sandler ↗
Mar 20, 24
▲ Overweight · 🎯$188
Price at call : $124.79 — upside +51%
Today : $251.1 — upside -25%
Expected +51% · Actual +13% · Reason (≥ +15%) : ✗ No
🎯 on JAZZ : 67% (12 calls matureds) · 📊 on Health : 42.5% · +4.1% (120 calls)
+12.7%
stock +13% · XLV +1%
matured Mar 20, 25
HC Wainwright & Co. ↗
Mar 14, 24
▲ Buy · 🎯$200
Price at call : $118.3 — upside +69%
Today : $251.1 — upside -20%
Expected +69% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on JAZZ : 50% (12 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
+16.6%
stock +17% · XLV -1%
matured Mar 14, 25
Cantor Fitzgerald ↗
Feb 29, 24
▲ Overweight · 🎯$180
Price at call : $118.85 — upside +51%
Today : $251.1 — upside -28%
Expected +51% · Actual +18% · Reason (≥ +15%) : ✓ Yes
🎯 on JAZZ : 70% (10 calls matureds) · 📊 on Health : 55.7% · +17.4% (115 calls)
+18.0%
stock +18% · XLV +2%
matured Feb 28, 25
RBC Capital ↗
Feb 29, 24
▲ Outperform · 🎯$195
Price at call : $118.85 — upside +64%
Today : $251.1 — upside -22%
Expected +64% · Actual +18% · Reason (≥ +15%) : ✓ Yes
🎯 on JAZZ : 75% (12 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
+18.0%
stock +18% · XLV +2%
matured Feb 28, 25
RBC Capital ↗
Nov 9, 23
▲ Outperform · 🎯$191
Price at call : $120.2 — upside +59%
Today : $251.1 — upside -24%
Expected +59% · Actual +6% · Reason (≥ +15%) : ✗ No
🎯 on JAZZ : 75% (12 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
+5.8%
stock +6% · XLV +18%
matured Nov 8, 24
Cantor Fitzgerald ↗
Aug 22, 23
▲ Overweight · 🎯$180
Price at call : $139.18 — upside +29%
Today : $251.1 — upside -28%
Expected +29% · Actual -18% · Reason (≥ +15%) : ✗ No
🎯 on JAZZ : 70% (10 calls matureds) · 📊 on Health : 55.7% · +17.4% (115 calls)
-17.7%
stock -18% · XLV +16%
matured Aug 21, 24
Cantor Fitzgerald ↗
Aug 14, 23
▲ Overweight · 🎯$180
Price at call : $140 — upside +29%
Today : $251.1 — upside -28%
Expected +29% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on JAZZ : 70% (10 calls matureds) · 📊 on Health : 55.7% · +17.4% (115 calls)
-20.2%
stock -20% · XLV +11%
matured Aug 13, 24
HC Wainwright & Co. ↗
Aug 11, 23
▲ Buy · 🎯$204
Price at call : $139.35 — upside +46%
Today : $251.1 — upside -19%
Expected +46% · Actual -22% · Reason (≥ +15%) : ✗ No
🎯 on JAZZ : 50% (12 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
-22.4%
stock -22% · XLV +10%
matured Aug 10, 24
RBC Capital ↗
Aug 10, 23
▲ Outperform · 🎯$201
Price at call : $139.35 — upside +44%
Today : $251.1 — upside -20%
Expected +44% · Actual -22% · Reason (≥ +15%) : ✗ No
🎯 on JAZZ : 75% (12 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
-22.4%
stock -22% · XLV +10%
matured Aug 9, 24
HC Wainwright & Co. ↗
May 15, 23
▲ Buy · 🎯$204
Price at call : $134.68 — upside +51%
Today : $251.1 — upside -19%
Expected +51% · Actual -17% · Reason (≥ +15%) : ✗ No
🎯 on JAZZ : 50% (12 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
-16.8%
stock -17% · XLV +9%
matured May 14, 24
RBC Capital ↗
May 11, 23
▲ Outperform · 🎯$202
Price at call : $135.72 — upside +49%
Today : $251.1 — upside -20%
Expected +49% · Actual -17% · Reason (≥ +15%) : ✗ No
🎯 on JAZZ : 75% (12 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
-16.6%
stock -17% · XLV +9%
matured May 10, 24
HC Wainwright & Co. ↗
Mar 6, 23
▲ Buy · 🎯$204
Price at call : $142.78 — upside +43%
Today : $251.1 — upside -19%
Expected +43% · Actual -17% · Reason (≥ +15%) : ✗ No
🎯 on JAZZ : 50% (12 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
-17.1%
stock -17% · XLV +12%
matured Mar 5, 24
RBC Capital ↗
Nov 10, 22
▲ Outperform · 🎯$207
Price at call : $149.15 — upside +39%
Today : $251.1 — upside -18%
Expected +39% · Actual -18% · Reason (≥ +15%) : ✗ No
🎯 on JAZZ : 75% (12 calls matureds) · 📊 on Health : 49.2% · +7.0% (195 calls)
-18.2%
stock -18% · XLV -5%
matured Nov 10, 23
BMO Capital ↗
Aug 4, 22
▲ Outperform · 🎯$188
Price at call : $153.72 — upside +22%
Today : $251.1 — upside -25%
Expected +22% · Actual -14% · Reason (≥ +15%) : ✗ No
🎯 on JAZZ : 30% (10 calls matureds) · 📊 on Health : 45.7% · +6.4% (35 calls)
-14.4%
stock -14% · XLV +2%
matured Aug 4, 23
▲ Buy · 🎯$191
Price at call : $151.17 — upside +26%
Today : $251.1 — upside -24%
Expected +26% · Actual -14% · Reason (≥ +15%) : ✗ No
🎯 on JAZZ : 60% (10 calls matureds) · 📊 on Health : 49.6% · +18.1% (119 calls)
-13.9%
stock -14% · XLV +1%
matured Aug 4, 23
▲ Buy · 🎯$194
Price at call : $143.06 — upside +36%
Today : $251.1 — upside -23%
Expected +36% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on JAZZ : 60% (10 calls matureds) · 📊 on Health : 49.6% · +18.1% (119 calls)
-11.5%
stock -12% · XLV +8%
matured Jun 14, 23
Piper Sandler ↗
May 5, 22
▲ Overweight · 🎯$193
Price at call : $153.22 — upside +26%
Today : $251.1 — upside -23%
Expected +26% · Actual -9% · Reason (≥ +15%) : ✗ No
🎯 on JAZZ : 67% (12 calls matureds) · 📊 on Health : 42.5% · +4.1% (120 calls)
-9.0%
stock -9% · XLV +3%
matured May 5, 23
HC Wainwright & Co. ↗
Mar 3, 22
▲ Buy · 🎯$215
Price at call : $152.9 — upside +41%
Today : $251.1 — upside -14%
Expected +41% · Actual -4% · Reason (≥ +15%) : ✗ No
🎯 on JAZZ : 50% (12 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
-4.4%
stock -4% · XLV -2%
matured Mar 3, 23
Piper Sandler ↗
Mar 2, 22
▲ Overweight · 🎯$197
Price at call : $153.1 — upside +29%
Today : $251.1 — upside -22%
Expected +29% · Actual -6% · Reason (≥ +15%) : ✗ No
🎯 on JAZZ : 67% (12 calls matureds) · 📊 on Health : 42.5% · +4.1% (120 calls)
-5.7%
stock -6% · XLV -3%
matured Mar 2, 23
HC Wainwright & Co. ↗
Aug 16, 21
▲ Buy · 🎯$210
Price at call : $140.2 — upside +50%
Today : $251.1 — upside -16%
Expected +50% · Actual +13% · Reason (≥ +15%) : ✗ No
🎯 on JAZZ : 50% (12 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
+13.2%
stock +13% · XLV -1%
matured Aug 16, 22
HC Wainwright & Co. ↗
Jun 21, 21
▲ Buy · 🎯$220
Price at call : $177.22 — upside +24%
Today : $251.1 — upside -12%
Expected +24% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on JAZZ : 50% (12 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
-15.9%
stock -16% · XLV -2%
matured Jun 21, 22
HC Wainwright & Co. ↗
May 17, 21
▲ Buy · 🎯$212
Price at call : $176.8 — upside +20%
Today : $251.1 — upside -16%
Expected +20% · Actual -14% · Reason (≥ +15%) : ✗ No
🎯 on JAZZ : 50% (12 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
-13.9%
stock -14% · XLV +7%
matured May 17, 22
▲ Buy · 🎯$228
Price at call : $165.75 — upside +38%
Today : $251.1 — upside -9%
Expected +38% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on JAZZ : 60% (10 calls matureds) · 📊 on Health : 49.6% · +18.1% (119 calls)
-7.6%
stock -8% · XLV +15%
matured Mar 1, 22
Piper Sandler ↗
Feb 24, 21
▲ Overweight · 🎯$205
Price at call : $170.74 — upside +20%
Today : $251.1 — upside -18%
Expected +20% · Actual -18% · Reason (≥ +15%) : ✗ No
🎯 on JAZZ : 67% (12 calls matureds) · 📊 on Health : 42.5% · +4.1% (120 calls)
-18.5%
stock -18% · XLV +15%
matured Feb 24, 22
BMO Capital ↗
May 6, 20
▲ Outperform · 🎯$193
Price at call : $109.45 — upside +76%
Today : $251.1 — upside -23%
Expected +76% · Actual +60% · Reason (≥ +15%) : ✓ Yes
🎯 on JAZZ : 30% (10 calls matureds) · 📊 on Health : 45.7% · +6.4% (35 calls)
+59.5%
stock +60% · XLV +25%
matured May 6, 21
BMO Capital ↗
Feb 26, 20
▲ Outperform · 🎯$205
Price at call : $116.59 — upside +76%
Today : $251.1 — upside -18%
Expected +76% · Actual +46% · Reason (≥ +15%) : ✓ Yes
🎯 on JAZZ : 30% (10 calls matureds) · 📊 on Health : 45.7% · +6.4% (35 calls)
+46.4%
stock +46% · XLV +17%
matured Feb 25, 21
BMO Capital ↗
May 8, 19
▲ Outperform · 🎯$208
Price at call : $140.59 — upside +48%
Today : $251.1 — upside -17%
Expected +48% · Actual -22% · Reason (≥ +15%) : ✗ No
🎯 on JAZZ : 30% (10 calls matureds) · 📊 on Health : 45.7% · +6.4% (35 calls)
-22.1%
stock -22% · XLV +11%
matured May 7, 20
BMO Capital ↗
Feb 27, 19
▲ Outperform · 🎯$206
Price at call : $137.83 — upside +49%
Today : $251.1 — upside -18%
Expected +49% · Actual -18% · Reason (≥ +15%) : ✗ No
🎯 on JAZZ : 30% (10 calls matureds) · 📊 on Health : 45.7% · +6.4% (35 calls)
-17.9%
stock -18% · XLV +2%
matured Feb 27, 20
BMO Capital ↗
Aug 8, 18
▲ Outperform · 🎯$206
Price at call : $175.58 — upside +17%
Today : $251.1 — upside -18%
Expected +17% · Actual -22% · Reason (≥ +15%) : ✗ No
🎯 on JAZZ : 30% (10 calls matureds) · 📊 on Health : 45.7% · +6.4% (35 calls)
-21.9%
stock -22% · XLV +1%
matured Aug 8, 19
BMO Capital ↗
May 9, 18
▲ Outperform · 🎯$201
Price at call : $161.08 — upside +25%
Today : $251.1 — upside -20%
Expected +25% · Actual -14% · Reason (≥ +15%) : ✗ No
🎯 on JAZZ : 30% (10 calls matureds) · 📊 on Health : 45.7% · +6.4% (35 calls)
-13.6%
stock -14% · XLV +9%
matured May 9, 19
BMO Capital ↗
Feb 28, 18
▲ Outperform · 🎯$199
Price at call : $140.67 — upside +41%
Today : $251.1 — upside -21%
Expected +41% · Actual -1% · Reason (≥ +15%) : ✗ No
🎯 on JAZZ : 30% (10 calls matureds) · 📊 on Health : 45.7% · +6.4% (35 calls)
-1.2%
stock -1% · XLV +12%
matured Feb 28, 19
▲ Buy · 🎯$168
Price at call : $135.31 — upside +24%
Today : $251.1 — upside -33%
Expected +24% · Actual +8% · Reason (≥ +15%) : ✗ No
🎯 on JAZZ : 60% (10 calls matureds) · 📊 on Health : 49.6% · +18.1% (119 calls)
+7.6%
stock +8% · XLV +14%
matured Nov 8, 18
▲ Buy · 🎯$172
Price at call : $149.49 — upside +15%
Today : $251.1 — upside -32%
Expected +15% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on JAZZ : 60% (10 calls matureds) · 📊 on Health : 49.6% · +18.1% (119 calls)
+9.4%
stock +9% · XLV +16%
matured Sep 25, 18
Cantor Fitzgerald ↗
Dec 16, 16
▲ Overweight · 🎯$187
Price at call : $105.39 — upside +77%
Today : $251.1 — upside -26%
Expected +77% · Actual +27% · Reason (≥ +15%) : ✓ Yes
🎯 on JAZZ : 70% (10 calls matureds) · 📊 on Health : 55.7% · +17.4% (115 calls)
+27.2%
stock +27% · XLV +20%
matured Dec 16, 17
BMO Capital ↗
Jun 29, 16
▲ Outperform
Actual +11% · Reason (≥ +15%) : ✗ No
🎯 on JAZZ : 30% (10 calls matureds) · 📊 on Health : 45.7% · +6.4% (35 calls)
+10.8%
stock +11% · XLV +12%
matured Jun 29, 17
Piper Sandler ↗
Nov 10, 15
▲ Overweight · 🎯$186
Price at call : $135.74 — upside +37%
Today : $251.1 — upside -26%
Expected +37% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on JAZZ : 67% (12 calls matureds) · 📊 on Health : 42.5% · +4.1% (120 calls)
-15.8%
stock -16% · XLV +1%
matured Nov 9, 16
▲ Buy · 🎯$210
Price at call : $170.6 — upside +23%
Today : $251.1 — upside -16%
Expected +23% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on JAZZ : 60% (10 calls matureds) · 📊 on Health : 49.6% · +18.1% (119 calls)
-19.7%
stock -20% · XLV -6%
matured Jun 28, 16
BMO Capital ↗
Feb 20, 15
▲ Outperform · 🎯$200
Price at call : $172.42 — upside +16%
Today : $251.1 — upside -20%
Expected +16% · Actual -27% · Reason (≥ +15%) : ✗ No
🎯 on JAZZ : 30% (10 calls matureds) · 📊 on Health : 45.7% · +6.4% (35 calls)
-27.2%
stock -27% · XLV -7%
matured Feb 20, 16
▲ Buy · 🎯$180
Price at call : $129.45 — upside +39%
Today : $251.1 — upside -28%
Expected +39% · Actual +36% · Reason (≥ +15%) : ✓ Yes
🎯 on JAZZ : 60% (10 calls matureds) · 📊 on Health : 49.6% · +18.1% (119 calls)
+36.4%
stock +36% · XLV +27%
matured May 9, 15
Cantor Fitzgerald ↗
Dec 4, 13
▲ Buy · 🎯$145
Price at call : $114.34 — upside +27%
Today : $251.1 — upside -42%
Expected +27% · Actual +56% · Reason (≥ +15%) : ✓ Yes
🎯 on JAZZ : 70% (10 calls matureds) · 📊 on Health : 55.7% · +17.4% (115 calls)
+56.0%
stock +56% · XLV +30%
matured Dec 4, 14
Cantor Fitzgerald ↗
Mar 11, 13
▲ Buy · 🎯$86
Price at call : $59.25 — upside +45%
Today : $251.1 — upside -66%
Expected +45% · Actual +156% · Reason (≥ +15%) : ✓ Yes
🎯 on JAZZ : 70% (10 calls matureds) · 📊 on Health : 55.7% · +17.4% (115 calls)
+155.6%
stock +156% · XLV +33%
matured Mar 11, 14
▲ Buy · 🎯$67
Price at call : $58.18 — upside +15%
Today : $251.1 — upside -73%
Expected +15% · Actual +161% · Reason (≥ +15%) : ✓ Yes
🎯 on JAZZ : 60% (10 calls matureds) · 📊 on Health : 49.6% · +18.1% (119 calls)
+161.2%
stock +161% · XLV +37%
matured Feb 27, 14
Piper Sandler ↗
Feb 27, 13
▲ Overweight · 🎯$69
Price at call : $57.78 — upside +19%
Today : $251.1 — upside -73%
Expected +19% · Actual +188% · Reason (≥ +15%) : ✓ Yes
🎯 on JAZZ : 67% (12 calls matureds) · 📊 on Health : 42.5% · +4.1% (120 calls)
+188.4%
stock +188% · XLV +37%
matured Feb 27, 14
▲ Buy · 🎯$64
Price at call : $53.88 — upside +19%
Today : $251.1 — upside -75%
Expected +19% · Actual +119% · Reason (≥ +15%) : ✓ Yes
🎯 on JAZZ : 60% (10 calls matureds) · 📊 on Health : 49.6% · +18.1% (119 calls)
+118.5%
stock +119% · XLV +37%
matured Nov 29, 13
Piper Sandler ↗
Aug 8, 12
▲ Overweight · 🎯$68
Price at call : $46.6 — upside +46%
Today : $251.1 — upside -73%
Expected +46% · Actual +75% · Reason (≥ +15%) : ✓ Yes
🎯 on JAZZ : 67% (12 calls matureds) · 📊 on Health : 42.5% · +4.1% (120 calls)
+75.4%
stock +75% · XLV +33%
matured Aug 8, 13
Frequently asked questions
Should I buy Jazz Pharmaceuticals stock?
This isn't buy advice. For Jazz Pharmaceuticals, the analyst consensus is "Buy", with an average price target of $282 (+12% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (3 calls tracked on Jazz Pharmaceuticals). We show the numbers — you decide.
Is it too late to buy Jazz Pharmaceuticals? How high can it go?
The most bullish analyst target on Jazz Pharmaceuticals is $310 (+23% above today's price); the average is $282. That's the upside they see. Check how reliable those analysts have actually been on Jazz Pharmaceuticals on our site before trusting it.
Is Jazz Pharmaceuticals still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 25 analysts have a real record on Jazz Pharmaceuticals, the best hitting 100% over 3 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in Jazz Pharmaceuticals? The case for and against
The arguments for and against, one by one, from the numbers: why invest in JAZZ (and why hesitate).
What has Jazz Pharmaceuticals's past performance been?
Historical returns and a "how much if I had invested" calculator: JAZZ performance & returns.
What is the best month to buy JAZZ?
The 12 months ranked by the stock's past returns: best & worst month to buy JAZZ.
Are insiders buying JAZZ stock?
Executives' and large holders' buys and sells, decoded: insider buying on JAZZ.
BIIB 
VRTX 
UNH 
REGN 
EW 
SRPT 
VEEV 
BSX